Switzerland: Genfit consolidates position in ACLF with Versantis acquisition

Europe and US listed, Genfit, a pioneer in liver disease research and development, has entered into an agreement to acquire Versantis, a private Swiss-based clinical stage biotech company focused on addressing the growing unmet medical needs in liver diseases. The acquisition consolidates Genfit’s position in ACLF (acute-on-chronic liver failure) and aligns with the strategy of…

You must be a HMI Subscriber to view this content.

Subscribe Now »